Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for PTCT

Stock Name	PTC Therapeutics Inc
Ticker	PTCT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US69366J2006
LEI	549300UJLWOIWFDGB318

Show aggregate PTCT holdings

News associated with PTCT

Bank of America Issues Pessimistic Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price: PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective reduced by Bank of America from $82.00 to $76.00 in a research report released on Wednesday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on PTCT. Wall Street Zen lowered PTC Therapeutics from a […] - 2025-08-21 04:58:55
PTC Therapeutics (NASDAQ:PTCT) Price Target Lowered to $73.00 at Wells Fargo & Company: PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective trimmed by Wells Fargo & Company from $79.00 to $73.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently has an overweight rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. Cantor Fitzgerald increased their […] - 2025-08-21 04:58:48
Noteworthy Monday Option Activity: ADBE, PTCT, RUM: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Adobe Inc (Symbol: ADBE), where a total of 32,627 contracts have traded so far, representing approximately 3.3 million underlying shares. That amounts to about 95.9% of - 2025-08-11 16:29:24
Natixis Advisors LLC Boosts Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT): Natixis Advisors LLC increased its holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 26.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,220 shares of the biopharmaceutical company’s stock after buying an additional 3,160 shares during the quarter. Natixis […] - 2025-08-11 05:47:02
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of “Moderate Buy” by Brokerages: Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have issued a buy […] - 2025-08-11 05:11:00
PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $80.00: PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price target lifted by UBS Group from $71.00 to $80.00 in a research note released on Tuesday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. PTCT has been the topic of several other reports. Citigroup increased their target price on shares of PTC […] - 2025-08-01 05:49:00
PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $120.00: PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective lifted by Cantor Fitzgerald from $112.00 to $120.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. Cantor Fitzgerald also issued estimates for PTC Therapeutics’ FY2025 earnings at $8.16 EPS and FY2026 earnings […] - 2025-08-01 05:48:59
PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Sold by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd lowered its holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 54.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,981 shares of the biopharmaceutical company’s stock after selling 6,043 shares during the quarter. Y Intercept Hong […] - 2025-07-31 04:39:00
Truist Financial Issues Positive Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price: PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective increased by Truist Financial from $80.00 to $86.00 in a report published on Tuesday morning,Benzinga reports. Truist Financial currently has a buy rating on the biopharmaceutical company’s stock. PTCT has been the topic of a number of other research reports. Wells Fargo & Company lifted […] - 2025-07-30 05:06:48
Bank of America Forecasts Strong Price Appreciation for PTC Therapeutics (NASDAQ:PTCT) Stock: PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price target increased by Bank of America from $68.00 to $84.00 in a research report released on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on the company. Royal Bank […] - 2025-07-30 04:22:59
Barclays Forecasts Strong Price Appreciation for PTC Therapeutics (NASDAQ:PTCT) Stock: PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective upped by Barclays from $42.00 to $46.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has an equal weight rating on the biopharmaceutical company’s stock. Several other analysts also recently commented on PTCT. Robert W. Baird lowered their price objective on PTC Therapeutics […] - 2025-07-30 04:22:55
PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up After Analyst Upgrade: PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s stock price gapped up prior to trading on Tuesday after Truist Financial raised their price target on the stock from $80.00 to $86.00. The stock had previously closed at $44.34, but opened at $47.50. Truist Financial currently has a buy rating on the stock. PTC Therapeutics shares […] - 2025-07-30 02:35:02
New York State Common Retirement Fund Buys 2,000 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT): New York State Common Retirement Fund boosted its stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 8.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,421 shares of the biopharmaceutical company’s stock after acquiring an additional 2,000 shares […] - 2025-07-25 05:44:49
Cerity Partners LLC Acquires Shares of 12,581 PTC Therapeutics, Inc. (NASDAQ:PTCT): Cerity Partners LLC bought a new position in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 12,581 shares of the biopharmaceutical company’s stock, valued at approximately $641,000. A number of other institutional investors have […] - 2025-07-25 04:50:54
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of “Moderate Buy” by Brokerages: PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has earned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, nine have assigned a buy recommendation and one […] - 2025-07-22 03:29:02
PTC Therapeutics, Inc. (NASDAQ:PTCT) Holdings Cut by Bank of New York Mellon Corp: Bank of New York Mellon Corp lowered its stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 0.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 216,443 shares of the biopharmaceutical company’s stock after selling 439 shares during the period. […] - 2025-07-21 04:26:50
PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock Position Decreased by Teacher Retirement System of Texas: Teacher Retirement System of Texas decreased its stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 8.9% during the first quarter, HoldingsChannel.com reports. The fund owned 18,681 shares of the biopharmaceutical company’s stock after selling 1,830 shares during the period. Teacher Retirement System of Texas’ holdings in PTC Therapeutics were worth $952,000 […] - 2025-07-15 04:24:39
10,287 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Purchased by Allspring Global Investments Holdings LLC: Allspring Global Investments Holdings LLC bought a new position in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) during the first quarter, HoldingsChannel reports. The institutional investor bought 10,287 shares of the biopharmaceutical company’s stock, valued at approximately $524,000. A number of other hedge funds have also recently bought and sold shares of PTCT. […] - 2025-07-11 04:31:12
PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Purchased by Diversified Trust Co: Diversified Trust Co boosted its holdings in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 2.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,147 shares of the biopharmaceutical company’s stock after buying an additional 329 shares during the period. […] - 2025-06-30 05:10:54
PTC Therapeutics (NASDAQ:PTCT) Coverage Initiated at Truist Financial: Equities researchers at Truist Financial started coverage on shares of PTC Therapeutics (NASDAQ:PTCT – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The firm set a “buy” rating and a $80.00 price target on the biopharmaceutical company’s stock. Truist Financial’s target price points to a potential upside […] - 2025-06-19 02:42:49
Pallas Capital Advisors LLC Makes New $353,000 Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT): Pallas Capital Advisors LLC purchased a new stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,925 shares of the biopharmaceutical company’s stock, valued at approximately $353,000. Several other institutional […] - 2025-06-13 05:38:53
PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Purchased by GAMMA Investing LLC: GAMMA Investing LLC lifted its stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 9,393.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 48,514 shares of the biopharmaceutical company’s stock after acquiring an additional 48,003 shares during the quarter. GAMMA Investing LLC’s holdings […] - 2025-06-13 04:36:51
Universal Beteiligungs und Servicegesellschaft mbH Takes Position in PTC Therapeutics, Inc. (NASDAQ:PTCT): Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 108,345 shares of the biopharmaceutical company’s stock, valued at approximately $4,891,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.14% of PTC […] - 2025-06-02 06:10:57
Wells Fargo & Company Boosts PTC Therapeutics (NASDAQ:PTCT) Price Target to $74.00: PTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its price target hoisted by equities research analysts at Wells Fargo & Company from $68.00 to $74.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price target suggests a potential upside of […] - 2025-05-29 02:31:00
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Recommendation of “Moderate Buy” by Brokerages: PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have given a hold recommendation, eight have assigned a buy recommendation and one has assigned a […] - 2025-05-28 04:46:51
PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up After Earnings Beat: PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price gapped up prior to trading on Wednesday following a better than expected earnings announcement. The stock had previously closed at $36.19, but opened at $39.40. PTC Therapeutics shares last traded at $39.92, with a volume of 455,281 shares trading hands. The biopharmaceutical company reported $10.04 […] - 2025-05-09 02:20:49
Analysts Set PTC Therapeutics, Inc. (NASDAQ:PTCT) PT at $63.92: Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have earned an average rating of “Moderate Buy” from the fifteen brokerages that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, eight have assigned a buy rating and one has […] - 2025-05-06 02:30:48
48,728 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Purchased by Raymond James Financial Inc.: Raymond James Financial Inc. acquired a new stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) during the fourth quarter, Holdings Channel reports. The firm acquired 48,728 shares of the biopharmaceutical company’s stock, valued at approximately $2,200,000. Several other institutional investors have also added to or reduced their stakes in the business. Smartleaf Asset Management […] - 2025-05-01 05:01:04
Federated Hermes Inc. Buys New Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT): Federated Hermes Inc. purchased a new position in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 47,828 shares of the biopharmaceutical company’s stock, valued at approximately $2,159,000. A number of other hedge funds and other institutional investors have also recently modified their holdings of […] - 2025-04-14 05:15:06
PTC Therapeutics, Inc. (NASDAQ:PTCT) Position Reduced by Prudential Financial Inc.: Prudential Financial Inc. trimmed its position in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) by 5.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 5,620 shares of the biopharmaceutical company’s stock after selling 330 shares during the quarter. Prudential Financial Inc.’s holdings in PTC Therapeutics were worth $254,000 at the end of the most […] - 2025-04-11 05:03:01

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) PTCT holdings

Date	Number of PTCT Shares Held	Base Market Value of PTCT Shares	Local Market Value of PTCT Shares	Change in PTCT Shares Held	Change in PTCT Base Value	Current Price per PTCT Share Held	Previous Price per PTCT Share Held
2025-12-03 (Wednesday)	55,716	USD 4,221,044	USD 4,221,044	0	USD -152,383	USD 75.76	USD 78.495
2025-12-02 (Tuesday)	55,716	USD 4,373,427	USD 4,373,427	1,980	USD 117,536	USD 78.495	USD 79.2
2025-12-01 (Monday)	53,736	USD 4,255,891	USD 4,255,891	0	USD -364,868	USD 79.2	USD 85.99
2025-11-28 (Friday)	53,736	USD 4,620,759	USD 4,620,759	132	USD -2,586	USD 85.99	USD 86.25
2025-11-27 (Thursday)	53,604	USD 4,623,345	USD 4,623,345	0	USD 0	USD 86.25	USD 86.25
2025-11-26 (Wednesday)	53,604	USD 4,623,345	USD 4,623,345	396	USD 210,806	USD 86.25	USD 82.93
2025-11-25 (Tuesday)	53,208	USD 4,412,539	USD 4,412,539	660	USD 217,632	USD 82.93	USD 79.83
2025-11-24 (Monday)	52,548	USD 4,194,907	USD 4,194,907	132	USD 81,823	USD 79.83	USD 78.47
2025-11-21 (Friday)	52,416	USD 4,113,084	USD 4,113,084	0	USD 105,357	USD 78.47	USD 76.46
2025-11-20 (Thursday)	52,416	USD 4,007,727	USD 4,007,727	-528	USD 5,161	USD 76.46	USD 75.6
2025-11-19 (Wednesday)	52,944	USD 4,002,566	USD 4,002,566	132	USD -47,586	USD 75.6	USD 76.69
2025-11-18 (Tuesday)	52,812	USD 4,050,152	USD 4,050,152	792	USD 117,440	USD 76.69	USD 75.6
2025-11-17 (Monday)	52,020	USD 3,932,712	USD 3,932,712	264	USD 35,485	USD 75.6	USD 75.3

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PTCT by Blackrock for IE00BDZVHG35

Show aggregate share trades of PTCT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,980 80.510 77.865 78.129 USD 154,696 52.90
2025-11-28 BUY 132 85.990* 52.61
2025-11-26 BUY 396 87.500 82.840 83.306 USD 32,989 52.28
2025-11-26 BUY 396 87.500 82.840 83.306 USD 32,989 52.28
2025-11-25 BUY 660 85.615 81.890 82.262 USD 54,293 52.12
2025-11-24 BUY 132 81.160 78.970 79.189 USD 10,453 51.98
2025-11-20 SELL -528 76.460* 51.72 Profit of 27,311 on sale
2025-11-19 BUY 132 75.600* 51.60
2025-11-18 BUY 792 76.690* 51.47
2025-11-17 BUY 264 77.430 74.700 74.973 USD 19,793 51.35
2025-11-14 BUY 132 76.800 74.085 74.356 USD 9,815 51.23
2025-11-12 BUY 132 74.950* 50.98
2025-11-10 BUY 132 72.610 70.540 70.747 USD 9,339 50.74
2025-11-06 BUY 132 73.980 71.360 71.622 USD 9,454 50.51
2025-11-04 BUY 132 68.800 66.215 66.473 USD 8,775 50.31
2025-10-30 BUY 660 69.880 67.140 67.414 USD 44,493 50.01
2025-10-29 BUY 264 67.350 68.140 68.061 USD 17,968 49.92
2025-10-22 SELL -528 66.520 67.580 67.474 USD -35,626 49.43 Loss of -9,525 on sale
2025-10-20 BUY 264 68.360 68.630 68.603 USD 18,111 49.22
2025-10-17 BUY 660 65.950 66.935 66.836 USD 44,112 49.13
2025-10-15 BUY 1,056 68.510 69.260 69.185 USD 73,059 49.01
2025-10-03 BUY 917 65.370 67.400 67.197 USD 61,620 48.82
2025-10-02 BUY 131 63.020 63.330 63.299 USD 8,292 48.73
2025-09-30 BUY 262 61.370 61.680 61.649 USD 16,152 48.58
2025-09-26 BUY 262 58.990 59.130 59.116 USD 15,488 48.44
2025-09-25 BUY 262 57.840 60.135 59.905 USD 15,695 48.39
2025-09-18 BUY 137 62.880 63.190 63.159 USD 8,653 48.30
2025-09-17 BUY 411 60.650 61.950 61.820 USD 25,408 48.22
2025-09-11 SELL -137 60.960 61.110 61.095 USD -8,370 48.07 Loss of -1,785 on sale
2025-09-10 BUY 274 58.330 59.000 58.933 USD 16,148 48.00
2025-07-17 SELL -274 48.530 49.450 49.358 USD -13,524 47.94 Loss of -389 on sale
2025-07-16 BUY 561 48.140 48.660 48.608 USD 27,269 47.94
2025-07-11 SELL -1,088 48.550 49.420 49.333 USD -53,674 47.92 Loss of -1,535 on sale
2025-07-02 BUY 7,480 49.150 49.565 49.523 USD 370,436 47.89
2025-06-25 BUY 272 48.890 49.435 49.381 USD 13,431 47.85
2025-06-20 BUY 1,329 50.200 51.210 51.109 USD 67,924 47.81
2025-06-11 BUY 262 50.820 52.070 51.945 USD 13,610 47.64
2025-06-10 BUY 262 51.740 52.325 52.267 USD 13,694 47.61
2025-06-04 SELL -131 51.130 51.570 51.526 USD -6,750 47.49 Loss of -529 on sale
2025-04-23 BUY 131 49.950 50.600 50.535 USD 6,620 47.71
2025-04-10 SELL -1,048 40.290 41.815 41.662 USD -43,662 47.90 Profit of 6,537 on sale
2025-04-08 SELL -131 39.770 45.030 44.504 USD -5,830 48.05 Profit of 465 on sale
2025-04-07 SELL -131 42.820 44.985 44.769 USD -5,865 48.11 Profit of 438 on sale
2025-04-04 SELL -655 43.240 46.160 45.868 USD -30,044 48.17 Profit of 1,508 on sale
2025-04-01 BUY 1,149 46.600 51.430 50.947 USD 58,538 48.19
2025-03-31 SELL -387 50.960 52.890 52.697 USD -20,394 48.15 Loss of -1,758 on sale
2025-03-21 BUY 2,505 57.140 57.340 57.320 USD 143,587 47.55
2025-03-14 SELL -1,936 54.500 55.650 55.535 USD -107,516 46.94 Loss of -16,636 on sale
2025-03-07 SELL -242 52.590 53.790 53.670 USD -12,988 46.50 Loss of -1,736 on sale
2025-03-04 SELL -121 51.800 52.750 52.655 USD -6,371 46.23 Loss of -778 on sale
2025-02-25 BUY 242 50.360 50.580 50.558 USD 12,235 45.73
2025-02-19 SELL -121 50.425 51.460 51.356 USD -6,214 45.38 Loss of -723 on sale
2025-02-13 BUY 363 49.670 49.980 49.949 USD 18,131 44.96
2025-02-12 BUY 121 48.930 48.990 48.984 USD 5,927 44.88
2025-02-11 BUY 484 48.635 49.650 49.549 USD 23,981 44.80
2024-12-30 SELL -4,041 45.770 45.950 45.932 USD -185,611 43.61 Loss of -9,375 on sale
2024-11-18 SELL -1,980 39.230 39.860 39.797 USD -78,798 41.42 Profit of 3,214 on sale
2024-11-08 SELL -132 44.280 46.550 46.323 USD -6,115 40.99 Loss of -704 on sale
2024-10-21 SELL -132 38.440 39.250 39.169 USD -5,170 0.00 Loss of -5,170 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,980	80.510	77.865	78.129	USD 154,696	52.90
2025-11-28	BUY	132			85.990*		52.61
2025-11-26	BUY	396	87.500	82.840	83.306	USD 32,989	52.28
2025-11-26	BUY	396	87.500	82.840	83.306	USD 32,989	52.28
2025-11-25	BUY	660	85.615	81.890	82.262	USD 54,293	52.12
2025-11-24	BUY	132	81.160	78.970	79.189	USD 10,453	51.98
2025-11-20	SELL	-528			76.460*		51.72 Profit of 27,311 on sale
2025-11-19	BUY	132			75.600*		51.60
2025-11-18	BUY	792			76.690*		51.47
2025-11-17	BUY	264	77.430	74.700	74.973	USD 19,793	51.35
2025-11-14	BUY	132	76.800	74.085	74.356	USD 9,815	51.23
2025-11-12	BUY	132			74.950*		50.98
2025-11-10	BUY	132	72.610	70.540	70.747	USD 9,339	50.74
2025-11-06	BUY	132	73.980	71.360	71.622	USD 9,454	50.51
2025-11-04	BUY	132	68.800	66.215	66.473	USD 8,775	50.31
2025-10-30	BUY	660	69.880	67.140	67.414	USD 44,493	50.01
2025-10-29	BUY	264	67.350	68.140	68.061	USD 17,968	49.92
2025-10-22	SELL	-528	66.520	67.580	67.474	USD -35,626	49.43 Loss of -9,525 on sale
2025-10-20	BUY	264	68.360	68.630	68.603	USD 18,111	49.22
2025-10-17	BUY	660	65.950	66.935	66.836	USD 44,112	49.13
2025-10-15	BUY	1,056	68.510	69.260	69.185	USD 73,059	49.01
2025-10-03	BUY	917	65.370	67.400	67.197	USD 61,620	48.82
2025-10-02	BUY	131	63.020	63.330	63.299	USD 8,292	48.73
2025-09-30	BUY	262	61.370	61.680	61.649	USD 16,152	48.58
2025-09-26	BUY	262	58.990	59.130	59.116	USD 15,488	48.44
2025-09-25	BUY	262	57.840	60.135	59.905	USD 15,695	48.39
2025-09-18	BUY	137	62.880	63.190	63.159	USD 8,653	48.30
2025-09-17	BUY	411	60.650	61.950	61.820	USD 25,408	48.22
2025-09-11	SELL	-137	60.960	61.110	61.095	USD -8,370	48.07 Loss of -1,785 on sale
2025-09-10	BUY	274	58.330	59.000	58.933	USD 16,148	48.00
2025-07-17	SELL	-274	48.530	49.450	49.358	USD -13,524	47.94 Loss of -389 on sale
2025-07-16	BUY	561	48.140	48.660	48.608	USD 27,269	47.94
2025-07-11	SELL	-1,088	48.550	49.420	49.333	USD -53,674	47.92 Loss of -1,535 on sale
2025-07-02	BUY	7,480	49.150	49.565	49.523	USD 370,436	47.89
2025-06-25	BUY	272	48.890	49.435	49.381	USD 13,431	47.85
2025-06-20	BUY	1,329	50.200	51.210	51.109	USD 67,924	47.81
2025-06-11	BUY	262	50.820	52.070	51.945	USD 13,610	47.64
2025-06-10	BUY	262	51.740	52.325	52.267	USD 13,694	47.61
2025-06-04	SELL	-131	51.130	51.570	51.526	USD -6,750	47.49 Loss of -529 on sale
2025-04-23	BUY	131	49.950	50.600	50.535	USD 6,620	47.71
2025-04-10	SELL	-1,048	40.290	41.815	41.662	USD -43,662	47.90 Profit of 6,537 on sale
2025-04-08	SELL	-131	39.770	45.030	44.504	USD -5,830	48.05 Profit of 465 on sale
2025-04-07	SELL	-131	42.820	44.985	44.769	USD -5,865	48.11 Profit of 438 on sale
2025-04-04	SELL	-655	43.240	46.160	45.868	USD -30,044	48.17 Profit of 1,508 on sale
2025-04-01	BUY	1,149	46.600	51.430	50.947	USD 58,538	48.19
2025-03-31	SELL	-387	50.960	52.890	52.697	USD -20,394	48.15 Loss of -1,758 on sale
2025-03-21	BUY	2,505	57.140	57.340	57.320	USD 143,587	47.55
2025-03-14	SELL	-1,936	54.500	55.650	55.535	USD -107,516	46.94 Loss of -16,636 on sale
2025-03-07	SELL	-242	52.590	53.790	53.670	USD -12,988	46.50 Loss of -1,736 on sale
2025-03-04	SELL	-121	51.800	52.750	52.655	USD -6,371	46.23 Loss of -778 on sale
2025-02-25	BUY	242	50.360	50.580	50.558	USD 12,235	45.73
2025-02-19	SELL	-121	50.425	51.460	51.356	USD -6,214	45.38 Loss of -723 on sale
2025-02-13	BUY	363	49.670	49.980	49.949	USD 18,131	44.96
2025-02-12	BUY	121	48.930	48.990	48.984	USD 5,927	44.88
2025-02-11	BUY	484	48.635	49.650	49.549	USD 23,981	44.80
2024-12-30	SELL	-4,041	45.770	45.950	45.932	USD -185,611	43.61 Loss of -9,375 on sale
2024-11-18	SELL	-1,980	39.230	39.860	39.797	USD -78,798	41.42 Profit of 3,214 on sale
2024-11-08	SELL	-132	44.280	46.550	46.323	USD -6,115	40.99 Loss of -704 on sale
2024-10-21	SELL	-132	38.440	39.250	39.169	USD -5,170	0.00 Loss of -5,170 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PTCT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	134,897	0	383,223	35.2%
2025-09-18	283,349	0	426,438	66.4%
2025-09-17	1,027,794	0	1,194,008	86.1%
2025-09-16	193,375	0	307,403	62.9%
2025-09-15	322,719	9	534,139	60.4%
2025-09-12	385,453	74	562,965	68.5%
2025-09-11	284,284	0	452,606	62.8%
2025-09-10	278,555	4	408,673	68.2%
2025-09-09	468,278	0	688,805	68.0%
2025-09-08	283,827	0	420,017	67.6%
2025-09-05	346,662	0	658,628	52.6%
2025-09-04	461,616	1,570	706,327	65.4%
2025-09-03	500,004	50	703,685	71.1%
2025-09-02	410,808	361	623,975	65.8%
2025-08-29	260,928	500	368,011	70.9%
2025-08-28	169,376	0	286,545	59.1%
2025-08-27	117,557	0	225,793	52.1%
2025-08-26	159,756	0	292,412	54.6%
2025-08-25	184,388	3	278,802	66.1%
2025-08-22	212,292	0	337,121	63.0%
2025-08-21	110,090	0	199,278	55.2%
2025-08-20	214,864	0	342,111	62.8%
2025-08-19	574,175	77	1,073,506	53.5%
2025-08-18	264,556	175	600,473	44.1%
2025-08-15	276,236	0	451,337	61.2%
2025-08-14	261,106	0	447,801	58.3%
2025-08-13	429,197	0	681,304	63.0%
2025-08-12	174,739	0	313,209	55.8%
2025-08-11	186,874	6,675	467,511	40.0%
2025-08-08	428,325	1,746	852,881	50.2%
2025-08-07	147,599	144	300,021	49.2%
2025-08-06	82,600	20	193,167	42.8%
2025-08-05	182,572	112	369,257	49.4%
2025-08-04	134,469	0	278,380	48.3%
2025-08-01	173,470	0	295,786	58.6%
2025-07-31	371,852	50	836,679	44.4%
2025-07-30	349,322	75	666,752	52.4%
2025-07-29	539,007	258	1,083,836	49.7%
2025-07-28	238,893	0	371,803	64.3%
2025-07-25	273,787	0	463,683	59.0%
2025-07-24	95,248	40	211,840	45.0%
2025-07-23	117,827	0	221,680	53.2%
2025-07-22	199,716	0	323,578	61.7%
2025-07-21	108,853	0	162,439	67.0%
2025-07-18	122,037	0	172,363	70.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE